Literature DB >> 9731697

Retinoid X receptor and c-cerbA/thyroid hormone receptor regulate erythroid cell growth and differentiation.

P Bartůnĕk1, M Zenke.   

Abstract

Nuclear receptors are important regulators of erythroid cell development. Here we investigated the impact of retinoid X receptor (RXR), retinoic acid receptor (RAR), and of the c-erbA/thyroid hormone (T3) receptor (c-erbA/TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor-dependent erythroid progenitors. RXR, RAR, and c-erbA/TR-specific ligands were found to induce erythroid-specific gene expression and to accelerate erythroid differentiation in culture, with T3 being most effective. Furthermore, while ligand-activated c-erbA/TR accelerated differentiation, unliganded c-erbA/TR effectively blocked differentiation and supported sustained progenitor growth in culture. Thus, c-erbA/TR appears to act as a binary switch affecting erythroid cell fate: unliganded c-erbA/TR supports growth while ligand-activated c-erbA/TR induces differentiation. Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF-1 and AF-2, or AF-2 only, or the entire DNA-binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR-specific effects. It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells. In marked contrast, expression of the dominant interfering deltaDNA-binding domain RXR, containing a deletion of the entire DNA-binding domain, was incompatible with erythroid cell growth in vitro, suggesting a pivotal role of RXR for erythroid cell development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731697     DOI: 10.1210/mend.12.9.0173

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Thyroid hormone regulates the obesity gene tub.

Authors:  N P Koritschoner; M Alvarez-Dolado; S M Kurz; M F Heikenwälder; C Hacker; F Vogel; A Muñoz; M Zenke
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

2.  DISP3, a sterol-sensing domain-containing protein that links thyroid hormone action and cholesterol metabolism.

Authors:  Martina Zikova; Alicia Corlett; Zdenka Bendova; Petr Pajer; Petr Bartunek
Journal:  Mol Endocrinol       Date:  2009-01-29

3.  Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation.

Authors:  Xiaofei Gao; Hsiang-Ying Lee; Wenbo Li; Randall Jeffrey Platt; M Inmaculada Barrasa; Qi Ma; Russell R Elmes; Michael G Rosenfeld; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-01       Impact factor: 11.205

4.  Congenital adenohypophyseal hypoplasia associated with secondary hypothyroidism in a 2-week-old Portuguese water dog.

Authors:  Arnon Gal; Lori T Raetzman; Kuldeep Singh
Journal:  Can Vet J       Date:  2012-06       Impact factor: 1.008

5.  Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.

Authors:  Keyue Ding; Khader Shameer; Hayan Jouni; Daniel R Masys; Gail P Jarvik; Abel N Kho; Marylyn D Ritchie; Catherine A McCarty; Christopher G Chute; Teri A Manolio; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

Review 6.  Role of Nuclear Receptors in Controlling Erythropoiesis.

Authors:  Valentina Pastori; Serena Pozzi; Agata Labedz; Sajeela Ahmed; Antonella Ellena Ronchi
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

7.  Anemia in Patients With Resistance to Thyroid Hormone α: A Role for Thyroid Hormone Receptor α in Human Erythropoiesis.

Authors:  Anja L M van Gucht; Marcel E Meima; Carla Moran; Maura Agostini; Anna Tylki-Szymanska; Malgorzata-Walasek Krajewska; Krystyna Chrzanowska; Alexandra Efthymiadou; Dionisios Chrysis; Korcan Demir; W Edward Visser; Theo J Visser; Krishna Chatterjee; Thamar B van Dijk; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.